| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1462399408000872 |
| P698 | PubMed publication ID | 19025715 |
| P2093 | author name string | John Sinclair | |
| P2860 | cites work | Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels | Q81974376 |
| Cytomegalovirus interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells | Q82911758 | ||
| Latency and reactivation of human cytomegalovirus | Q83946800 | ||
| Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5 | Q59345017 | ||
| Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells | Q60193093 | ||
| Diagnosis of cytomegalovirus infection | Q69842136 | ||
| Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection | Q72096313 | ||
| Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells | Q73035410 | ||
| Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues | Q73107960 | ||
| Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome | Q73223910 | ||
| Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus | Q73378332 | ||
| Effect of interleukin-10 on dendritic cell maturation and function | Q73396250 | ||
| CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis | Q73945688 | ||
| Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12 | Q74602340 | ||
| Infection of dendritic cells by murine cytomegalovirus induces functional paralysis | Q74825846 | ||
| Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells | Q77357447 | ||
| Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy | Q77383438 | ||
| Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells | Q78311722 | ||
| Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells | Q79912737 | ||
| Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10 | Q80475705 | ||
| An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling | Q81355877 | ||
| Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells | Q81358155 | ||
| CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection | Q81441256 | ||
| Plasmacytoid dendritic cells: linking innate and adaptive immunity | Q24558695 | ||
| Innate immune recognition | Q27860721 | ||
| Viruses and interferon: a fight for supremacy | Q28220397 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Topics in herpesvirus genomics and evolution | Q28298372 | ||
| Toll-like receptor control of the adaptive immune responses | Q29547305 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures | Q29615028 | ||
| Human cytomegalovirus infection of human hematopoietic progenitor cells | Q33588798 | ||
| Modulation of natural killer cells by human cytomegalovirus | Q33744384 | ||
| CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12. | Q33920135 | ||
| Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers | Q33932471 | ||
| Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology | Q33943132 | ||
| Betaherpesviruses in transplant recipients | Q33944145 | ||
| Chemokines and dendritic cell traffic. | Q34002668 | ||
| Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression | Q34118755 | ||
| Cross-presentation, dendritic cells, tolerance and immunity | Q34178099 | ||
| The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics | Q34282306 | ||
| Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. | Q34298631 | ||
| Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee | Q34340674 | ||
| Regulation of dendritic cell recruitment by chemokines | Q34505316 | ||
| Gene expression profiling in immune cells using microarray. | Q34508994 | ||
| Dendritic cell subsets in health and disease. | Q34582889 | ||
| Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. | Q34589567 | ||
| Congenital cytomegalovirus infection: review of the epidemiology and outcome | Q34605965 | ||
| Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion | Q34731393 | ||
| Human cytomegalovirus: Latency and reactivation in the myeloid lineage | Q34731399 | ||
| Beta-herpesvirus challenges in the transplant recipient | Q34918418 | ||
| Strategies to prevent CMV infection in the neonate | Q34980748 | ||
| Natural type I interferon-producing cells as a link between innate and adaptive immunity | Q35024776 | ||
| Molecular mechanisms of dendritic cell sublineage development from human hematopoietic progenitor/stem cells | Q35156313 | ||
| Langerhans cells - dendritic cells of the epidermis. | Q35219303 | ||
| Significance of human herpesviruses to transplant recipients | Q35587145 | ||
| Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system | Q35827470 | ||
| Asymptomatic primary cytomegalovirus infection: virologic and immunologic features | Q44042219 | ||
| Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals | Q44042248 | ||
| Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity | Q44636439 | ||
| Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients | Q44934297 | ||
| Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells | Q45400024 | ||
| Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. | Q46391163 | ||
| Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape | Q47871211 | ||
| Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection | Q47898614 | ||
| The outcome of congenital cytomegalovirus infection in relation to maternal antibody status | Q50539344 | ||
| Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. | Q52169908 | ||
| Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. | Q52573306 | ||
| Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. | Q52600469 | ||
| Breast Milk and the Risk of Cytomegalovirus Infection | Q56431619 | ||
| Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection | Q57000544 | ||
| The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy | Q57010367 | ||
| Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection | Q57083074 | ||
| Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells | Q57158184 | ||
| Dendritic cell function in cytomegalovirus-infected patients with mononucleosis | Q59345011 | ||
| Human cytomegalovirus latent infection of granulocyte-macrophage progenitors | Q35945151 | ||
| Plasmacytoid dendritic cells in immunity | Q35953140 | ||
| Dendritic cells control B cell growth and differentiation | Q35963666 | ||
| Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity | Q36088964 | ||
| Functional diversity and plasticity of human dendritic cell subsets | Q36090933 | ||
| Mechanisms of MHC class I-restricted antigen processing and cross-presentation | Q36266466 | ||
| Dendritic cell biology in herpesvirus infections. | Q36280391 | ||
| MHC class II compartment subtypes: structure and function | Q36335779 | ||
| Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
| CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha | Q36367113 | ||
| Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | Q36403406 | ||
| Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency | Q36463607 | ||
| Lipid metabolism, atherogenesis and CD1-restricted antigen presentation | Q36465013 | ||
| Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). | Q36468518 | ||
| Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality | Q36684512 | ||
| Duration, combination and timing: the signal integration model of dendritic cell activation | Q36778219 | ||
| Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on. | Q36884194 | ||
| Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients | Q36967479 | ||
| Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products | Q37571081 | ||
| A soluble factor(s) released by MRC-5 cells early and late after human cytomegalovirus infection induces maturation of monocyte-derived dendritic cells. | Q37862068 | ||
| Impact of cytomegalovirus infection on organ transplant recipients | Q37897931 | ||
| Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. | Q39020960 | ||
| Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells | Q39681740 | ||
| Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells | Q39683371 | ||
| Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus | Q39787577 | ||
| Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
| Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes | Q39960937 | ||
| Inhibition of CD1 antigen presentation by human cytomegalovirus | Q40011111 | ||
| Dendritic cell-induced apoptosis of human cytomegalovirus-infected fibroblasts promotes cross-presentation of pp65 to CD8+ T cells | Q40033802 | ||
| Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages | Q40113755 | ||
| Human cytomegalovirus productively infects primary differentiated macrophages | Q40115481 | ||
| Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion | Q40148627 | ||
| Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells | Q40624760 | ||
| Transcriptional reprogramming of dendritic cells by differentiation stimuli | Q40782210 | ||
| Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells | Q40809435 | ||
| Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens | Q40811217 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Herpesvirus infections in persons infected with human immunodeficiency virus | Q40938423 | ||
| The human cytomegalovirus major immediate-early gene | Q41454473 | ||
| Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line | Q41642688 | ||
| Epidermal Langerhans cell development and differentiation | Q41750476 | ||
| Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism | Q41839444 | ||
| In-vitro differentiation of mature dendritic cells from human blood monocytes | Q43088853 | ||
| Induction of polymorphonuclear leukocyte response by human cytomegalovirus | Q43812719 | ||
| P921 | main subject | dendritic cell | Q506253 |
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | e35 | |
| P577 | publication date | 2008-11-24 | |
| P1433 | published in | Expert Reviews in Molecular Medicine | Q15755244 |
| P1476 | title | Manipulation of dendritic cell functions by human cytomegalovirus | |
| P478 | volume | 10 |
| Q37706830 | Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice |
| Q34594928 | Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells |
| Q26863328 | Herpesviruses and intermediate filaments: close encounters with the third type |
| Q55401180 | Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4+ and CD8+ T Cells. |
| Q41909075 | Human cytomegalovirus infection of langerhans-type dendritic cells does not require the presence of the gH/gL/UL128-131A complex and is blocked after nuclear deposition of viral genomes in immature cells |
| Q34422068 | Human cytomegalovirus tropism for mucosal myeloid dendritic cells |
| Q38234937 | Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus. |
| Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
| Q27348688 | Murid herpesvirus-4 exploits dendritic cells to infect B cells |
| Q40844893 | Pattern of circulation of MCMV mimicking natural infection upon oronasal inoculation |
| Q41991559 | Subviral dense bodies of human cytomegalovirus stimulate maturation and activation of monocyte-derived immature dendritic cells. |
| Q36215044 | The Mouse Cytomegalovirus Gene m42 Targets Surface Expression of the Protein Tyrosine Phosphatase CD45 in Infected Macrophages |
| Q36302615 | The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? |
Search more.